Abstract
Background Artemisinin resistant parasites have been documented recently in the Cambodia-Thailand border area, which has been the epicenter of parasite resistance to antimalarials in the past. In September 2010, the USAID funded Malaria Control in Cambodia (MCC) project, in collaboration with National Malaria Control program (CNM) and with technical and financial support from WHO, conducted community Day-3 surveillance for Pf (+) to gather evidence of drug resistance in the area. From June, 2011, the community surveillance expanded follow up to Day-28.
Highlights
Artemisinin resistant parasites have been documented recently in the Cambodia-Thailand border area, which has been the epicenter of parasite resistance to antimalarials in the past
Malaria patients are treated with DHA-PIP for three days with directly observed therapy (DOT)
Cases identified positive on Day7/Day-28 are referred for second line treatment with Quinine +Tetracycline for 7 days
Summary
Artemisinin resistant parasites have been documented recently in the Cambodia-Thailand border area, which has been the epicenter of parasite resistance to antimalarials in the past. From June, 2011, the community surveillance expanded follow up to Day-28
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
